Nanobiotix Announces EUR 2.8 Million Grant From bpifrance to Accelerate Development of NBTXR3 in a Third New Indication

Marketwired
Nanobiotix Announces EUR 2.8 Million Grant From bpifrance to Accelerate Development of NBTXR3 in a Third New Indication
NANOBIOTIX Logo
View Comments (0)